Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

(Reuters) - Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand for its glucose monitors to offset a ...

Abbott Laboratories (NYSE:ABT) on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand for its glucose monitors to ...

Abbott Banks on Glucose Monitors, New Launches to Ride Out China, Currency Hit By Christy Santhosh and Puyaan Singh (Reuters) - Abbott Laboratories on Wednesday forecast 2025 profit that came in ...

has seen a large boost to sales from strong demand for FreeStyle Libre - its continuous glucose monitor. Abbott had been facing supply issues for its Libre devices and said it will meet the demand ...

For fourth-quarter fiscal 2024, Abbott projects non-GAAP earnings between $1.31 per share and $1.37 per share. The Zacks Consensus Estimate for earnings has been steady at $1.34 per share over the ...

Portable monitors are gaining popularity, and it’s easy to see why. They are a boon to both desktop and laptop users. While portable monitors might not reach the large screen sizes of ...

A fan in the stands at Bridgestone Arena was hit by a puck at the 17:03 mark of the first period between the Nashville Predators and Minnesota Wild on Saturday night. Play was stopped briefly so ...

Wi-Fi-enabled baby monitors offer a lot of modern conveniences, but they also come saddled with potenial privacy risks. A non-Wi-Fi baby monitor is the most straightforward way to prevent hackers ...